Skip to main content
Advertisement
Advertisement

TPST

TPST logo

Tempest Therapeutics, Inc. Common Stock

0.83
USD
Sponsored
-0.02
-2.47%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

0.82

0.00
-0.48%

TPST Earnings Reports

Positive Surprise Ratio

TPST beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.35
Implied change from Q2 26 (Revenue/ EPS)
--
/
+2.94%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-55.70%

Tempest Therapeutics, Inc. Common Stock earnings per share and revenue

On Aug 13, 2026, TPST reported earnings of -0.34 USD per share (EPS) for Q2 26, missing the estimate of -0.30 USD, resulting in a -11.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +13.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.35 USD, with revenue projected to reach -- USD, implying an increase of 2.94% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Tempest Therapeutics, Inc. Common Stock reported EPS of -$0.34, missing estimates by -11.11%, and revenue of $0.00, 0% as expectations.
The stock price moved up 13.46%, changed from $1.04 before the earnings release to $1.18 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on -- analysts, Tempest Therapeutics, Inc. Common Stock is expected to report EPS of -$0.35 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement